Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05287516 · ClinicalTrials.gov registry record · NA
Validation of a Digital Visual Analogue Scale for Appetite Measurement
A NA study, sponsored by General Mills.
- Completed
- Registry status
- NA
- Development phase
- 130
- Enrollment target
NCT05287516: Completed NA study, sponsored by General Mills.
NCT05287516 is a NA study that has completed, run by General Mills. The registered enrollment target is 130 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05287516, a NA study, has completed, sponsored by General Mills.
- COMPLETED
- Registry status
- NA
- Development phase
- 130 participants
- Enrollment target
Study Summary
The objective of the study is to validate a newly developed digital visual analog scales with a mobile app for measuring human appetite and compare it with a traditional paper-based visual analog scales for appetite measurement.
Interventions
- OTHER Breakfast meal
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 130 participants |
| Start Date | 2022-04-01 |
| Est. Completion | 2022-05-30 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05287516
The ClinicalTrials.gov registry entry for NCT05287516 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 130 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is General Mills, which has 4 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Breakfast meal is the first listed.
NCT05287516 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05287516 about?
NCT05287516 is a clinical study titled "Validation of a Digital Visual Analogue Scale for Appetite Measurement". The objective of the study is to validate a newly developed digital visual analog scales with a mobile app for measuring human appetite and compare it with a traditional paper-based visual analog scales for appetite measurement.
What is the current status of trial NCT05287516?
This trial is currently completed. It is a NA study. The enrollment target is 130 participants. The study started on 2022-04-01. Estimated completion is 2022-05-30.
What interventions are being tested in trial NCT05287516?
The interventions under investigation include: Breakfast meal (OTHER).
Who is sponsoring clinical trial NCT05287516?
This trial is sponsored by General Mills, which has 4 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.